Literature DB >> 12637249

Role for complement in mediating intestinal nitric oxide synthase-2 and superoxide dismutase expression.

Michael C Montalto1, Melanie L Hart, James E Jordan, Koichiro Wada, Gregory L Stahl.   

Abstract

Inducible nitric oxide synthase (iNOS) and superoxide dismutase (SOD) play an important role in the pathology of ischemia-reperfusion. This study sought to determine if the proinflammatory effects of complement modulate iNOS and SOD in the rat after gastrointestinal ischemia and reperfusion (GI/R). An inhibitory or noninhibitory anti-complement component 5 (C5) monoclonal antibody (18A or 16C, respectively) was administered before GI/R. RT-PCR revealed a significant increase in intestinal iNOS mRNA compared with sham after GI/R that was attenuated significantly by 18A. Immunohistochemistry demonstrated increased iNOS protein expression within the intestinal crypts after GI/R. Cu/Zn SOD (mRNA and protein) was unaffected by GI/R, whereas Cu/Zn SOD activity was reduced significantly. Mn SOD protein expression was decreased significantly by GI/R. Anti-C5 preserved Cu/Zn SOD activity and Mn SOD protein expression. Staining for nitrotyrosine showed that anti-C5 treatment reduced protein nitration in the reperfused intestine. Immunohistochemistry demonstrated prominent phosphorylated (p) inhibitory factor-kappaB (IkappaB)-alpha staining of intestinal tissue after GI/R, whereas anti-C5 reduced p-IkappaB-alpha expression. These data indicate that complement may mediate tissue damage during GI/R by increasing intestinal iNOS and decreasing the activity and protein levels of Cu/Zn SOD and Mn SOD, respectively.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12637249     DOI: 10.1152/ajpgi.00029.2003

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  11 in total

Review 1.  Peroxisome proliferator-activated receptors ligands and ischemia-reperfusion injury.

Authors:  Rosanna Di Paola; Salvatore Cuzzocrea
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-03-13       Impact factor: 3.000

2.  Ischemic post-conditioning to counteract intestinal ischemia/reperfusion injury.

Authors:  Yan-Fang Guan; Timothy A Pritts; Marshall H Montrose
Journal:  World J Gastrointest Pathophysiol       Date:  2010-10-15

Review 3.  Ischemia-reperfusion injury of the intestine and protective strategies against injury.

Authors:  Ismail Hameed Mallick; Wenxuan Yang; Marc C Winslet; Alexander M Seifalian
Journal:  Dig Dis Sci       Date:  2004-09       Impact factor: 3.199

4.  Association of serum nitrate and nitrite levels with longitudinal assessments of disease activity and damage in systemic lupus erythematosus and lupus nephritis.

Authors:  Jim C Oates; Stephanie R Shaftman; Sally E Self; Gary S Gilkeson
Journal:  Arthritis Rheum       Date:  2008-01

5.  Complement component 3 inhibition by an antioxidant is neuroprotective after cerebral ischemia and reperfusion in mice.

Authors:  Jiwon Yang; Hye-Na Ahn; Minsun Chang; Purnima Narasimhan; Pak H Chan; Yun Seon Song
Journal:  J Neurochem       Date:  2012-12-28       Impact factor: 5.372

Review 6.  Evolution and Function of Thioester-Containing Proteins and the Complement System in the Innate Immune Response.

Authors:  Upasana Shokal; Ioannis Eleftherianos
Journal:  Front Immunol       Date:  2017-06-29       Impact factor: 7.561

Review 7.  The complement system in ischemia-reperfusion injuries.

Authors:  William B Gorsuch; Elvina Chrysanthou; Wilhelm J Schwaeble; Gregory L Stahl
Journal:  Immunobiology       Date:  2012-08-07       Impact factor: 3.144

8.  Tuscan black kale sprout extract bioactivated with myrosinase: a novel natural product for neuroprotection by inflammatory and oxidative response during cerebral ischemia/reperfusion injury in rat.

Authors:  Sabrina Giacoppo; Maria Galuppo; Gina Rosalinda De Nicola; Renato Iori; Placido Bramanti; Emanuela Mazzon
Journal:  BMC Complement Altern Med       Date:  2015-11-06       Impact factor: 3.659

9.  Inducible Nitric Oxide Synthase (iNOS) Is a Novel Negative Regulator of Hematopoietic Stem/Progenitor Cell Trafficking.

Authors:  Mateusz Adamiak; Ahmed Abdelbaset-Ismail; Joseph B Moore; J Zhao; Ahmed Abdel-Latif; Marcin Wysoczynski; Mariusz Z Ratajczak
Journal:  Stem Cell Rev Rep       Date:  2017-02       Impact factor: 5.739

Review 10.  The complement system in glioblastoma multiforme.

Authors:  T A M Bouwens van der Vlis; J M Kros; D A M Mustafa; R T A van Wijck; L Ackermans; P M van Hagen; P J van der Spek
Journal:  Acta Neuropathol Commun       Date:  2018-09-12       Impact factor: 7.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.